Research output per year
Research output per year
Personal profile
Biography
Amos de Jong obtained his PhD in Drug Innovation from the Utrecht University in 2024. Amos’ PhD thesis focuses on the regulatory aspects of decentralized clinical trials and encompasses both qualitative and quantitative research methods. He works as a Postdoc at the Julius Center (Epidemiology of Infectious Diseases) of the University Medical Center Utrecht. In this Postdoc position, his research will focus on the regulatory aspects of (operational and methodological) clinical trial innovation, focusing on adaptive platform trials.
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
- 2 Article
-
Factors affecting the feasibility of post-authorisation RCTs for conditionally authorised anticancer medicines: a multistakeholder perspective from a qualitative focus group study
van Hattem, C. C., de Jong, A. J., de Groot, J. S., Hoekman, J., Broekman, K. E., Sonke, G. S., van Hennik, P. B. & Bloem, L. T., 9 Nov 2024, In: BMJ Open. 14, 11, e084483.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
Regulatory readiness to facilitate the appropriate use of innovation in clinical trials: The case of decentralized clinical trial approaches
de Jong, A. J., Zuidgeest, M. G. P., Santa-Ana-Tellez, Y., de Boer, A., Gardarsdottir, H., Nov 2024, In: Drug Discovery Today. 29, 11, 8 p., 104180.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile1 Downloads (Pure)